HB 7005

1
A reviser's bill to be entitled
2An act relating to the Florida Statutes; repealing ss.
329.0086, 29.014, 120.551, 215.18(2), 216.181(17),
4218.503(6), 253.034(6)(f)2., 287.057(14)(b) and (25),
5339.135(8), 375.041(6), 394.76(3)(b)2., 402.305(2)(g),
6420.0005(2), 420.36(4)(d), 497.161(1)(g), 499.0051(2)(a),
7499.0121(6)(d) and (e), and 1004.065, F.S., all of which
8provisions have become inoperative by noncurrent repeal or
9expiration and, pursuant to s. 11.242(5)(b) and (i), may
10be omitted from the 2007 Florida Statutes only through a
11reviser's bill duly enacted by the Legislature; amending
12s. 29.008, F.S., to conform to the repeal of s. 29.0086,
13F.S.; and amending ss. 499.003, 499.005, 499.012,
14499.0121, 499.01211, 499.0122, 499.014, and 499.051, F.S.,
15to conform to the repeal of s. 499.0121(6)(d) and (e),
16F.S.; providing an effective date.
17
18Be It Enacted by the Legislature of the State of Florida:
19
20     Section 1.  Section 29.0086, Florida Statutes, is repealed.
21
22Reviser's note.--The cited section, which relates to
23the Article V Technology Board, was repealed pursuant
24to its own terms, effective July 1, 2006.
25
26     Section 2.  Section 29.014, Florida Statutes, is repealed.
27
28Reviser's note.--The cited section, which relates to
29the Article V Indigent Services Advisory Board was
30repealed by s. 70, ch. 2005-236, Laws of Florida,
31effective July 1, 2006. Since the section was not
32repealed by a "current session" of the Legislature, it
33may be omitted from the 2007 Florida Statutes only
34through a reviser's bill duly enacted by the
35Legislature. See s. 11.242(5)(b) and (i).
36
37     Section 3.  Section 120.551, Florida Statutes, is repealed.
38
39Reviser's note.--The cited section, which relates to
40Internet publication of agency notices in the Florida
41Administrative Weekly, was repealed pursuant to its
42own terms, effective July 1, 2006.
43
44     Section 4.  Subsection (2) of section 215.18, Florida
45Statutes, is repealed.
46
47Reviser's note.--The cited subsection, which relates
48to extension of a repayment period, for the 2005-2006
49fiscal year only, for certain funds to meet
50deficiencies resulting from 2004 hurricanes, expired
51pursuant to its own terms, effective July 1, 2006.
52
53     Section 5.  Subsection (17) of section 216.181, Florida
54Statutes, is repealed.
55
56Reviser's note.--The cited subsection, which relates
57to amendments to approved operating budgets
58authorizing the expenditure of moneys from the Working
59Capital Fund as specifically authorized in the General
60Appropriations Act, expired pursuant to its own terms,
61effective July 1, 2006.
62
63     Section 6.  Subsection (6) of section 218.503, Florida
64Statutes, is repealed.
65
66Reviser's note.--The cited subsection, which relates
67to a discretionary per-vehicle surcharge by a
68governing authority of a municipality with a resident
69population of 300,000 or more on or after April 1,
701999, which has been declared in a state of financial
71emergency pursuant to s. 218.503, expired pursuant to
72its own terms, effective June 30, 2006.
73
74     Section 7.  Subparagraph 2. of paragraph (f) of subsection
75(6) of section 253.034, Florida Statutes, is repealed.
76
77Reviser's note.--The cited subparagraph, which relates
78to a requirement that certain surplus state lands that
79were acquired from a municipality for no consideration
80prior to 1958 must be first offered for reconveyance
81to the municipality at no cost, expired pursuant to
82its own terms, effective July 1, 2006.
83
84     Section 8.  Paragraph (b) of subsection (14) and subsection
85(25) of section 287.057, Florida Statutes, are repealed.
86
87Reviser's note.--Paragraph (14)(b), which authorizes
88the Department of Children and Family Services to
89enter into certain agreements with a private provider
90to finance, design, and construct a forensic treatment
91facility, expired pursuant to its own terms, effective
92July 1, 2006. Subsection (25), which authorizes the
93Department of Management Services to issue an
94invitation to negotiate to contract for specified
95additional beds for certain correctional facilities,
96for the 2005-2006 fiscal year only, expired pursuant
97to its own terms, effective July 1, 2006.
98
99     Section 9.  Subsection (8) of section 339.135, Florida
100Statutes, is repealed.
101
102Reviser's note.--The cited subsection, which relates
103to certain increased appropriations for projects
104funded within the Department of Transportation,
105expired pursuant to its own terms, effective July 1,
1062006.
107
108     Section 10.  Subsection (6) of section 375.041, Florida
109Statutes, is repealed.
110
111Reviser's note.--The cited subsection, which
112authorizes appropriations of funds allocated to the
113Land Acquisition Trust Fund for water quality issues
114in the General Appropriations Act for the 2005-2006
115fiscal year only, expired pursuant to its own terms,
116effective July 1, 2006.
117
118     Section 11.  Subparagraph 2. of paragraph (b) of subsection
119(3) of section 394.76, Florida Statutes, is repealed.
120
121Reviser's note.--The cited subparagraph, which
122requires a 75-to-25 state-to-local ratio for specified
123contracted community alcohol and mental health
124services and programs for the 2005-2006 fiscal year
125only, expired pursuant to its own terms, effective
126July 1, 2006.
127
128     Section 12.  Paragraph (g) of subsection (2) of section
129402.305, Florida Statutes, is repealed.
130
131Reviser's note.--The cited paragraph, which requires
132the Department of Children and Family Services to
133provide at least one Child Care Competency Exam in
134Spanish during the 2005-2006 fiscal year, expired
135pursuant to its own terms, effective July 1, 2006.
136
137     Section 13.  Subsection (2) of section 420.0005, Florida
138Statutes, is repealed.
139
140Reviser's note.--The cited subsection, which permits,
141for the 2005-2006 fiscal year only, any unappropriated
142balance in the State Housing Trust Fund in the
143Department of Community Affairs to be transferred by
144the General Appropriations Act to the Emergency
145Management Preparedness and Assistance Trust Fund,
146expired pursuant to its own terms, effective July 1,
1472006.
148
149     Section 14.  Paragraph (d) of subsection (4) of section
150420.36, Florida Statutes, is repealed.
151
152Reviser's note.--The cited paragraph, which authorizes
153transfer, by the General Appropriations Act and for
154the 2005-2006 fiscal year only, of any unappropriated
155balance in the Energy Consumption Trust Fund to the
156Emergency Management Preparedness and Assistance Trust
157Fund, expired pursuant to its own terms, effective
158July 1, 2006.
159
160     Section 15.  Paragraph (g) of subsection (1) of section
161497.161, Florida Statutes, is repealed.
162
163Reviser's note.--The cited paragraph, which provides
164for extraordinary rulemaking authority relating to the
165merging of chapters 470 and 497, specifies that the
166rulemaking authority and rules adopted under that
167authority expired July 1, 2006.
168
169     Section 16.  Paragraph (a) of subsection (2) of section
170499.0051, Florida Statutes, is repealed.
171
172Reviser's note.--The cited paragraph, which relates to
173failure to authenticate pedigree papers relating to
174legend drug distribution and which is replaced by
175similar provisions in paragraph (2)(b) effective July
1761, 2006, expired pursuant to its own terms, effective
177July 1, 2006.
178
179     Section 17.  Paragraphs (d) and (e) of subsection (6) of
180section 499.0121, Florida Statutes, are repealed, and paragraphs
181(f), (g), and (h) of that subsection are amended to read:
182     499.0121  Storage and handling of prescription drugs;
183recordkeeping.--The department shall adopt rules to implement
184this section as necessary to protect the public health, safety,
185and welfare.  Such rules shall include, but not be limited to,
186requirements for the storage and handling of prescription drugs
187and for the establishment and maintenance of prescription drug
188distribution records.
189     (6)  RECORDKEEPING.--The department shall adopt rules that
190require keeping such records of prescription drugs as are
191necessary for the protection of the public health.
192     (d)(f)1.  Effective July 1, 2006, each person who is
193engaged in the wholesale distribution of a prescription drug and
194who is not the manufacturer of that drug must, before each
195wholesale distribution of such drug, provide to the person who
196receives the drug a pedigree paper as defined in s. 499.003(31).
197     2.  A repackager must comply with this paragraph.
198     3.  The pedigree paper requirements in this paragraph do
199not apply to compressed medical gases or veterinary legend
200drugs.
201     4.  Each wholesale distributor of prescription drugs must
202maintain separate and distinct from other required records all
203statements that are required under subparagraph 1.
204     5.  In order to verify compliance with subparagraph (d)1.,
205each manufacturer of a prescription drug sold in this state must
206make available upon request distribution documentation related
207to its sales of prescription drugs, regardless of whether the
208prescription drug was sold directly by the manufacturer to a
209person in Florida.
210     5.6.  Subparagraph 1. is satisfied when a wholesale
211distributor takes title to, but not possession of, a
212prescription drug and the prescription drug's manufacturer ships
213the prescription drug directly to a person authorized by law to
214purchase prescription drugs for the purpose of administering or
215dispensing the drug, as defined in s. 465.003, or a member of an
216affiliated group, as described in paragraph (f)(h), with the
217exception of a repackager.
218     a.  The wholesale distributor must deliver to the recipient
219of the prescription drug, within 14 days after the shipment
220notification from the manufacturer, an invoice and the following
221sworn statement: "This wholesale distributor purchased the
222specific unit of the prescription drug listed on the invoice
223directly from the manufacturer, and the specific unit of
224prescription drug was shipped by the manufacturer directly to a
225person authorized by law to administer or dispense the legend
226drug, as defined in s. 465.003, Florida Statutes, or a member of
227an affiliated group, as described in s. 499.0121(6)(f)
228499.0121(6)(h), Florida Statutes, with the exception of a
229repackager." The invoice must contain a unique cross-reference
230to the shipping document sent by the manufacturer to the
231recipient of the prescription drug.
232     b.  The manufacturer of the prescription drug shipped
233directly to the recipient under this section must provide and
234the recipient of the prescription drug must acquire, within 14
235days after receipt of the prescription drug, a shipping document
236from the manufacturer that contains, at a minimum:
237     (I)  The name and address of the manufacturer, including
238the point of origin of the shipment, and the names and addresses
239of the wholesaler and the purchaser.
240     (II)  The name of the prescription drug as it appears on
241the label.
242     (III)  The quantity, dosage form, and strength of the
243prescription drug.
244     (IV)  The date of the shipment from the manufacturer.
245     c.  The wholesale distributor must also maintain and make
246available to the department, upon request, the lot number of
247such drug if not contained in the shipping document acquired by
248the recipient.
249     6.7.  Failure of the manufacturer to provide, the recipient
250to acquire, or the wholesale distributor to deliver, the
251documentation required under subparagraph 5.6. shall constitute
252failure to acquire or deliver a pedigree paper under s.
253499.0051. Forgery by the manufacturer, the recipient, or the
254wholesale distributor of the documentation required to be
255acquired or delivered under subparagraph 5.6. shall constitute
256forgery of a pedigree paper under s. 499.0051.
257     7.8.  The department may, by rule, specify alternatives to
258compliance with subparagraph 1. for a prescription drug in the
259inventory of a permitted prescription drug wholesaler as of June
26030, 2006, and the return of a prescription drug purchased prior
261to July 1, 2006. The department may specify time limits for such
262alternatives.
263     (e)(g)  Each wholesale distributor, except for a
264manufacturer, shall annually provide the department with a
265written list of all wholesale distributors and manufacturers
266from whom the wholesale distributor purchases prescription
267drugs. A wholesale distributor, except a manufacturer, shall
268notify the department not later than 10 days after any change to
269either list. Such portions of the information required pursuant
270to this paragraph which are a trade secret, as defined in s.
271812.081, shall be maintained by the department as trade secret
272information is required to be maintained under s. 499.051.
273     (f)(h)1.  This paragraph applies only to an affiliated
274group, as defined by s. 1504 of the Internal Revenue Code of
2751986, as amended, which is composed of chain drug entities,
276including at least 50 retail pharmacies, warehouses, or
277repackagers, which are members of the same affiliated group, if
278the affiliated group:
279     a.  Discloses to the department the names of all its
280members; and
281     b.  Agrees in writing to provide records on prescription
282drug purchases by members of the affiliated group not later than
28348 hours after the department requests such records, regardless
284of the location where the records are stored.
285     2.  Each warehouse within the affiliated group must comply
286with all applicable federal and state drug wholesale permit
287requirements and must purchase, receive, hold, and distribute
288prescription drugs only to a retail pharmacy or warehouse within
289the affiliated group. Such a warehouse is exempt from providing
290a pedigree paper in accordance with paragraph (d) paragraphs
291(d), (e), and (f) to its affiliated group member warehouse or
292retail pharmacy, provided that:
293     a.  Any affiliated group member that purchases or receives
294a prescription drug from outside the affiliated group must
295receive a pedigree paper if the prescription drug is distributed
296in or into this state and a pedigree paper is required under
297this section and must authenticate the documentation as required
298in subsection (4), regardless of whether the affiliated group
299member is directly subject to regulation under this chapter; and
300     b.  The affiliated group makes available to the department
301on request all records related to the purchase or acquisition of
302prescription drugs by members of the affiliated group,
303regardless of the location where the records are stored, if the
304prescription drugs were distributed in or into this state.
305     3.  If a repackager repackages prescription drugs solely
306for distribution to its affiliated group members for the
307exclusive distribution to and among retail pharmacies that are
308members of the affiliated group to which the repackager is a
309member:
310     a.  The repackager must:
311     (I)  In lieu of the written statement required by paragraph
312(d), paragraph (e), or paragraph (f), for all repackaged
313prescription drugs distributed in or into this state, state in
314writing under oath with each distribution of a repackaged
315prescription drug to an affiliated group member warehouse or
316repackager: "All repackaged prescription drugs are purchased by
317the affiliated group directly from the manufacturer or from a
318prescription drug wholesaler that purchased the prescription
319drugs directly from the manufacturer.";
320     (II)  Purchase all prescription drugs it repackages:
321     (A)  Directly from the manufacturer; or
322     (B)  From a prescription drug wholesaler that purchased the
323prescription drugs directly from the manufacturer; and
324     (III)  Maintain records in accordance with this section to
325document that it purchased the prescription drugs directly from
326the manufacturer or that its prescription drug wholesale
327supplier purchased the prescription drugs directly from the
328manufacturer.
329     b.  All members of the affiliated group must provide to
330agents of the department on request records of purchases by all
331members of the affiliated group of prescription drugs that have
332been repackaged, regardless of the location where the records
333are stored or where the repackager is located.
334
335Reviser's note.--Paragraphs (6)(d) and (e), which
336relate to certain recordkeeping requirements for
337persons engaged in the manufacture or wholesale
338distribution of a prescription drug and placement of
339prescription drugs on a list of specified drugs,
340expired pursuant to their own terms, effective July 1,
3412006. Paragraphs (6)(f), (g), and (h) are redesignated
342and amended to conform to the expiration of paragraphs
343(d) and (e).
344
345     Section 18.  Section 1004.065, Florida Statutes, is
346repealed.
347
348Reviser's note.--The cited section, which relates to a
349limitation on university and direct-support
350organization financings, expired pursuant to its own
351terms, effective July 1, 2006.
352
353     Section 19.  Paragraph (f) of subsection (1) of section
35429.008, Florida Statutes, is amended to read:
355     29.008  County funding of court-related functions.--
356     (1)  Counties are required by s. 14, Art. V of the State
357Constitution to fund the cost of communications services,
358existing radio systems, existing multiagency criminal justice
359information systems, and the cost of construction or lease,
360maintenance, utilities, and security of facilities for the
361circuit and county courts, public defenders' offices, state
362attorneys' offices, guardian ad litem offices, and the offices
363of the clerks of the circuit and county courts performing court-
364related functions. For purposes of this section, the term
365"circuit and county courts" shall include the offices and
366staffing of the guardian ad litem programs. The county
367designated under s. 35.05(1) as the headquarters for each
368appellate district shall fund these costs for the appellate
369division of the public defender's office in that county. For
370purposes of implementing these requirements, the term:
371     (f)  "Communications services" are defined as any
372reasonable and necessary transmission, emission, and reception
373of signs, signals, writings, images, and sounds of intelligence
374of any nature by wire, radio, optical, audio equipment, or other
375electromagnetic systems and includes all facilities and
376equipment owned, leased, or used by judges, clerks, public
377defenders, state attorneys, and all staff of the state courts
378system, state attorneys' offices, public defenders' offices, and
379clerks of the circuit and county courts performing court-related
380functions. Such system or services shall include, but not be
381limited to:
382     1.  Telephone system infrastructure, including computer
383lines, telephone switching equipment, and maintenance, and
384facsimile equipment, wireless communications, cellular
385telephones, pagers, and video teleconferencing equipment and
386line charges. Each county shall continue to provide access to a
387local carrier for local and long distance service and shall pay
388toll charges for local and long distance service.
389     2.  All computer networks, systems and equipment, including
390computer hardware and software, modems, printers, wiring,
391network connections, maintenance, support staff or services
392including any county-funded support staff located in the offices
393of the circuit court, county courts, state attorneys, and public
394defenders, training, supplies, and line charges necessary for an
395integrated computer system to support the operations and
396management of the state courts system, the offices of the public
397defenders, the offices of the state attorneys, and the offices
398of the clerks of the circuit and county courts and the
399capability to connect those entities and reporting data to the
400state as required for the transmission of revenue, performance
401accountability, case management, data collection, budgeting, and
402auditing purposes. The integrated computer system shall be
403operational by July 1, 2006, and, at a minimum, permit the
404exchange of financial, performance accountability, case
405management, case disposition, and other data across multiple
406state and county information systems involving multiple users at
407both the state level and within each judicial circuit and be
408able to electronically exchange judicial case background data,
409sentencing scoresheets, and video evidence information stored in
410integrated case management systems over secure networks. Once
411the integrated system becomes operational, counties may reject
412requests to purchase communication services included in this
413subparagraph not in compliance with standards, protocols, or
414processes adopted by the board established pursuant to former s.
41529.0086.
416     3.  Courier messenger and subpoena services.
417     4.  Auxiliary aids and services for qualified individuals
418with a disability which are necessary to ensure access to the
419courts. Such auxiliary aids and services include, but are not
420limited to, sign language interpretation services required under
421the federal Americans with Disabilities Act other than services
422required to satisfy due-process requirements and identified as a
423state funding responsibility pursuant to ss. 29.004, 29.005,
42429.006, and 29.007, real-time transcription services for
425individuals who are hearing impaired, and assistive listening
426devices and the equipment necessary to implement such
427accommodations.
428
429Reviser's note.--Amended to conform to the expiration
430of s. 29.0086, effective July 1, 2006; that expiration
431is confirmed by this act.
432
433     Section 20.  Subsection (31) of section 499.003, Florida
434Statutes, is amended to read:
435     499.003  Definitions of terms used in ss. 499.001-
436499.081.--As used in ss. 499.001-499.081, the term:
437     (31)  "Pedigree paper" means:
438     (a)  A document required pursuant to s. 499.0121(6)(d) or
439(e); or
440     (a)(b)1.  Effective July 1, 2006, a document or electronic
441form approved by the Department of Health and containing
442information that records each distribution of any given legend
443drug, from sale by a pharmaceutical manufacturer, through
444acquisition and sale by any wholesaler or repackager, until
445final sale to a pharmacy or other person administering or
446dispensing the drug. The information required to be included on
447the form approved by the department pursuant to this paragraph
448subparagraph must at least detail the amount of the legend drug;
449its dosage form and strength; its lot numbers; the name and
450address of each owner of the legend drug and his or her
451signature; its shipping information, including the name and
452address of each person certifying delivery or receipt of the
453legend drug; an invoice number, a shipping document number, or
454another number uniquely identifying the transaction; and a
455certification that the recipient wholesaler has authenticated
456the pedigree papers. If the manufacturer or repackager has
457uniquely serialized the individual legend drug unit, that
458identifier must also be included on the form approved pursuant
459to this paragraph subparagraph. It must also include the name,
460address, telephone number and, if available, e-mail contact
461information of each wholesaler involved in the chain of the
462legend drug's custody; or
463     (b)2.  A statement, under oath, in written or electronic
464form, confirming that a wholesale distributor purchases and
465receives the specific unit of the prescription drug directly
466from the manufacturer of the prescription drug and distributes
467the prescription drug directly, or through an intracompany
468transfer, to a chain pharmacy warehouse or a person authorized
469by law to purchase prescription drugs for the purpose of
470administering or dispensing the drug, as defined in s. 465.003.
471For purposes of this subsection paragraph, the term "chain
472pharmacy warehouse" means a wholesale distributor permitted
473pursuant to s. 499.01 that maintains a physical location for
474prescription drugs that functions solely as a central warehouse
475to perform intracompany transfers of such drugs to a member of
476its affiliated group as described in s. 499.0121(6)(f)1.
477499.0121(6)(h)1.
478     1.a.  The information required to be included pursuant to
479this paragraph subparagraph must include:
480     a.(I)  The following statement: "This wholesale distributor
481purchased the specific unit of the prescription drug directly
482from the manufacturer."
483     b.(II)  The manufacturer's national drug code identifier
484and the name and address of the wholesaler and the purchaser of
485the prescription drug.
486     c.(III)  The name of the prescription drug as it appears on
487the label.
488     d.(IV)  The quantity, dosage form, and strength of the
489prescription drug.
490     2.b.  The wholesale distributor must also maintain and make
491available to the department, upon request, the point of origin
492of the prescription drugs, including intracompany transfers; the
493date of the shipment from the manufacturer to the wholesale
494distributor; the lot numbers of such drugs; and the invoice
495numbers from the manufacturer.
496
497The department may adopt rules and forms relating to the
498requirements of this subsection.
499
500Reviser's note.--Amended to conform to the expiration
501of s. 499.0121(6)(d) and (e) by their own terms,
502effective July 1, 2006; those expirations are
503confirmed by this act.
504
505     Section 21.  Subsection (29) of section 499.005, Florida
506Statutes, is amended to read:
507     499.005  Prohibited acts.--It is unlawful for a person to
508perform or cause the performance of any of the following acts in
509this state:
510     (29)  The receipt of a prescription drug pursuant to a
511wholesale distribution without either first receiving a pedigree
512paper that was attested to as accurate and complete by the
513wholesale distributor or complying with the provisions of s.
514499.0121(6)(d)5. 499.0121(6)(f)6.
515
516Reviser's note.--Amended to conform to the expiration
517of s. 499.0121(6)(d) and (e) by their own terms,
518effective July 1, 2006; those expirations are
519confirmed by this act.
520
521     Section 22.  Paragraphs (e), (f), (g), and (h) of
522subsection (2) of section 499.012, Florida Statutes, are amended
523to read:
524     499.012  Wholesale distribution; definitions; permits;
525applications; general requirements.--
526     (2)  The following types of wholesaler permits are
527established:
528     (e)  Nonresident prescription drug manufacturer permit.--A
529nonresident prescription drug manufacturer permit is required
530for any person that is a manufacturer of prescription drugs, or
531the distribution point for a manufacturer of prescription drugs,
532and located outside of this state, or that is an entity to whom
533an approved new drug application has been issued by the United
534States Food and Drug Administration, or the contracted
535manufacturer of the approved new drug application holder, and
536located outside the United States, which engages in the
537wholesale distribution in this state of the prescription drugs
538it manufactures or is responsible for manufacturing. Each such
539manufacturer or entity must be permitted by the department and
540comply with all the provisions required of a wholesale
541distributor under ss. 499.001-499.081, except s. 499.0121(6)(d),
542(e), or (f).
543     1.  A person that distributes prescription drugs that it
544did not manufacture must also obtain an out-of-state
545prescription drug wholesaler permit pursuant to this section to
546engage in the wholesale distribution of the prescription drugs
547manufactured by another person and comply with the requirements
548of an out-of-state prescription drug wholesaler.
549     2.  Any such person must comply with the licensing or
550permitting requirements of the jurisdiction in which the
551establishment is located and the federal act, and any product
552wholesaled into this state must comply with ss. 499.001-499.081.
553If a person intends to import prescription drugs from a foreign
554country into this state, the nonresident prescription drug
555manufacturer must provide to the department a list identifying
556each prescription drug it intends to import and document
557approval by the United States Food and Drug Administration for
558such importation.
559     (f)  Freight forwarder permit.--A freight forwarder permit
560is required for any person that engages in the distribution of a
561legend drug as a freight forwarder unless the person is a common
562carrier. The storage, handling, and recordkeeping of such
563distributions must comply with the requirements for wholesale
564distributors under s. 499.0121, except those set forth in s.
565499.0121(6)(d), (e), or (f). A freight forwarder must provide
566the source of the legend drugs with a validated airway bill,
567bill of lading, or other appropriate documentation to evidence
568the exportation of the product.
569     (g)  A veterinary prescription drug wholesaler permit.--A
570veterinary prescription drug wholesaler permit is required for
571any person that engages in the distribution of veterinary
572prescription drugs in or into this state. A veterinary
573prescription drug wholesaler that also distributes prescription
574drugs subject to, defined by, or described by s. 503(b) of the
575Federal Food, Drug, and Cosmetic Act which it did not
576manufacture must obtain a permit as a prescription drug
577wholesaler, an out-of-state prescription drug wholesaler, or a
578limited prescription drug veterinary wholesaler in lieu of the
579veterinary prescription drug wholesaler permit. A veterinary
580prescription drug wholesaler must comply with the requirements
581for wholesale distributors under s. 499.0121, except those set
582forth in s. 499.0121(6)(d), (e), or (f).
583     (h)  Limited prescription drug veterinary wholesaler
584permit.--Unless engaging in the activities of and permitted as a
585prescription drug manufacturer, nonresident prescription drug
586manufacturer, prescription drug wholesaler, or out-of-state
587prescription drug wholesaler, a limited prescription drug
588veterinary wholesaler permit is required for any person that
589engages in the distribution in or into this state of veterinary
590prescription drugs and prescription drugs subject to, defined
591by, or described by s. 503(b) of the Federal Food, Drug, and
592Cosmetic Act under the following conditions:
593     1.  The person is engaged in the business of wholesaling
594prescription and veterinary legend drugs to persons:
595     a.  Licensed as veterinarians practicing on a full-time
596basis;
597     b.  Regularly and lawfully engaged in instruction in
598veterinary medicine;
599     c.  Regularly and lawfully engaged in law enforcement
600activities;
601     d.  For use in research not involving clinical use; or
602     e.  For use in chemical analysis or physical testing or for
603purposes of instruction in law enforcement activities, research,
604or testing.
605     2.  No more than 30 percent of total annual prescription
606drug sales may be prescription drugs approved for human use
607which are subject to, defined by, or described by s. 503(b) of
608the Federal Food, Drug, and Cosmetic Act.
609     3.  The person is not permitted, licensed, or otherwise
610authorized in any state to wholesale prescription drugs subject
611to, defined by, or described by s. 503(b) of the Federal Food,
612Drug, and Cosmetic Act to any person who is authorized to sell,
613distribute, purchase, trade, or use these drugs on or for
614humans.
615     4.  A limited prescription drug veterinary wholesaler that
616applies to the department for a new permit or the renewal of a
617permit must submit a bond of $20,000, or other equivalent means
618of security acceptable to the department, such as an irrevocable
619letter of credit or a deposit in a trust account or financial
620institution, payable to the Florida Drug, Device, and Cosmetic
621Trust Fund. The purpose of the bond is to secure payment of any
622administrative penalties imposed by the department and any fees
623and costs incurred by the department regarding that permit which
624are authorized under state law and which the permittee fails to
625pay 30 days after the fine or costs become final. The department
626may make a claim against such bond or security until 1 year
627after the permittee's license ceases to be valid or until 60
628days after any administrative or legal proceeding authorized in
629ss. 499.001-499.081 which involves the permittee is concluded,
630including any appeal, whichever occurs later.
631     5.  A limited prescription drug veterinary wholesaler must
632maintain at all times a license or permit to engage in the
633wholesale distribution of prescription drugs in compliance with
634laws of the state in which it is a resident.
635     6.  A limited prescription drug veterinary wholesaler must
636comply with the requirements for wholesale distributors under s.
637499.0121, except that a limited prescription drug veterinary
638wholesaler is not required to provide a pedigree paper as
639required by s. 499.0121(6)(d) 499.0121(6)(f) upon the wholesale
640distribution of a prescription drug to a veterinarian.
641     7.  A limited prescription drug veterinary wholesaler may
642not return to inventory for subsequent wholesale distribution
643any prescription drug subject to, defined by, or described by s.
644503(b) of the Federal Food, Drug, and Cosmetic Act which has
645been returned by a veterinarian.
646     8.  An out-of-state prescription drug wholesaler's permit
647or a limited prescription drug veterinary wholesaler permit is
648not required for an intracompany sale or transfer of a
649prescription drug from an out-of-state establishment that is
650duly licensed to engage in the wholesale distribution of
651prescription drugs in its state of residence to a licensed
652limited prescription drug veterinary wholesaler in this state if
653both wholesalers conduct wholesale distributions of prescription
654drugs under the same business name. The recordkeeping
655requirements of s. 499.0121(6) must be followed for this
656transaction.
657
658Reviser's note.--Amended to conform to the expiration
659of s. 499.0121(6)(d) and (e) by their own terms,
660effective July 1, 2006; those expirations are
661confirmed by this act.
662
663     Section 23.  Subsection (3) of section 499.01211, Florida
664Statutes, is amended to read:
665     499.01211  Drug Wholesaler Advisory Council.--
666     (3)  The council shall review ss. 499.001-499.081 and the
667rules adopted to administer ss. 499.001-499.081 annually,
668provide input to the department regarding all proposed rules to
669administer ss. 499.001-499.081, make written recommendation to
670the secretary of the department regarding the listing of all
671specified drugs pursuant to s. 499.0121(6)(e), make
672recommendations to the department to improve the protection of
673the prescription drugs and public health, make recommendations
674to improve coordination with other states' regulatory agencies
675and the federal government concerning the wholesale distribution
676of drugs, and make recommendations to minimize the impact of
677regulation of the wholesale distribution industry while ensuring
678protection of the public health.
679
680Reviser's note.--Amended to conform to the expiration
681of s. 499.0121(6)(e) by its own terms, effective July
6821, 2006; that expiration is confirmed by this act.
683
684     Section 24.  Paragraph (c) of subsection (2) of section
685499.0122, Florida Statutes, is amended to read:
686     499.0122  Medical oxygen and veterinary legend drug retail
687establishments; definitions, permits, general requirements.--
688     (2)
689     (c)  A retail establishment must comply with all of the
690wholesale distribution requirements of s. 499.0121 except those
691set forth in s. 499.0121(6)(d).
692
693Reviser's note.--Amended to conform to the expiration
694of s. 499.0121(6)(d) by its own terms, effective July
6951, 2006; that expiration is confirmed by this act.
696
697     Section 25.  Subsection (3) of section 499.014, Florida
698Statutes, is amended to read:
699     499.014  Distribution of legend drugs by hospitals, health
700care entities, charitable organizations, and return or
701destruction companies; permits, general requirements.--
702     (3)  Storage, handling, and recordkeeping of these
703distributions must comply with the requirements for wholesale
704distributors under s. 499.0121, except those set forth in s.
705499.0121(6)(d), (e), or (f).
706
707Reviser's note.--Amended to conform to the expiration
708of s. 499.0121(6)(d) and (e) by their own terms,
709effective July 1, 2006; those expirations are
710confirmed by this act.
711
712     Section 26.  Subsection (7) of section 499.051, Florida
713Statutes, is amended to read:
714     499.051  Inspections and investigations.--
715     (7)  The complaint and all information obtained pursuant to
716the investigation by the department are confidential and exempt
717from the provisions of s. 119.07(1) and s. 24(a), Art. I of the
718State Constitution until the investigation and the enforcement
719action are completed. However, trade secret information
720contained therein as defined by s. 812.081(1)(c) shall remain
721confidential and exempt from the provisions of s. 119.07(1) and
722s. 24(a), Art. I of the State Constitution, as long as the
723information is retained by the department.  This subsection does
724not prohibit the department from using such information for
725regulatory or enforcement proceedings under this chapter or from
726providing such information to any law enforcement agency or any
727other regulatory agency.  However, the receiving agency shall
728keep such records confidential and exempt as provided in this
729subsection.  In addition, this subsection is not intended to
730prevent compliance with the provisions of s. 499.0121(6)(d),
731(e), or (f), and the pedigree papers required in that subsection
732shall not be deemed a trade secret.
733
734Reviser's note.--Amended to conform to the expiration
735of s. 499.0121(6)(d) and (e) by their own terms,
736effective July 1, 2006; those expirations are
737confirmed by this act.
738
739     Section 27.  This act shall take effect on the 60th day
740after adjournment sine die of the session of the Legislature in
741which enacted.


CODING: Words stricken are deletions; words underlined are additions.